For household contacts of individuals with COVID-19, taking ensitrelvir within 72 hours of symptoms is effective at preventing infection and generally well tolerated.
A large study found pregnant women infected with SARS-CoV-2 had a lower incidence of Long COVID compared to non-pregnant ...
Moscow said there is "no evidence of a new or unidentified virus" as viral rumors spread on Russian social media.
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses ...
Trump administration has now targeted Covid-19-related research grants for termination, citing the pandemic as being over.
Ensitrelvir reduced transmission of SARS-CoV-2 by 67% when given to uninfected household contacts of a person with COVID-19 ...
In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.
CoV-2, has affected millions of people worldwide. Despite the virus’ primary target being the respiratory system, it has ...
The Office for Long COVID Research and Practice was instrumental in coordinating the U.S. government’s initiatives to treat, ...
Has there been any progress in figuring out how to treat long COVID? I have been dealing with the symptoms for two years, and ...
Full COVID-19 vaccination may reduce post-COVID-19 condition risk by 27%, though more research is needed, especially for ...
Scientists used advanced data analysis and machine learning to identify the viral proteins that may trigger autoimmune disorders such as type 1 diabetes and rheumatoid arthritis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results